Virtu Financial LLC Equillium, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	SELL	$0.56 - $1.24 $5,374 - $11,901	-9,598 Reduced 33.89%	18,724 $14,000
Q4 2022 Feb 15, 2023	BUY	$0.83 - $2.26 $3,470 - $9,449	4,181 Added 17.32%	28,322 $31,000
Q3 2022 Nov 07, 2022	BUY	$1.93 - $3.14 $46,592 - $75,802	24,141 New	24,141 $54,000
Q1 2021 May 19, 2021	SELL	$5.03 - $10.5 $91,782 - $191,593	-18,247 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$3.48 - $6.58 $63,499 - $120,065	18,247 New	18,247 $98,000

11.5M

38.1K

Ticker EQ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,352,100
Market Cap $47.1M
Description
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.